Chapter CSB 2

CSB 2.012 Note (fg) Delta1-dihydrotestosterone.

CSB 2.012 Note (fr) 4-dihydrotestosterone, which is also called stanolone.

CSB 2.012 Note (g) Drostanolone.

CSB 2.012 Note (gg) Ethylestrenol.

CSB 2.012 Note (gr) Fluoxymesterone.

CSB 2.012 Note (h) Formebulone, which is also called fromebolone.

CSB 2.012 Note (hg) Furazabol.

CSB 2.012 Note (hr) 13beta-ethyl-17beta-hydroxygon-4-en-3-one.

CSB 2.012 Note (i) 4-hydroxytestosterone.

CSB 2.012 Note (ig) 4-hydroxy-19-nortestosterone.

CSB 2.012 Note (ir) Mestanolone.

CSB 2.012 Note (j) Mesterolone.

CSB 2.012 Note (jg) Methandienone, which is also called methandrostenolone.

CSB 2.012 Note (jr) Methandriol.

CSB 2.012 Note (k) Methasterone.

CSB 2.012 Note (kg) Methenolone.

CSB 2.012 Note (kr) 17alpha-methyl-3beta, 17beta-dihydroxy-5alpha-androstane.

CSB 2.012 Note (L) 17alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane.

CSB 2.012 Note (Lg) 17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene.

CSB 2.012 Note (Lr) 17alpha-methyl-4-hydroxynandrolone.

CSB 2.012 Note (m) Methyldienolone.

CSB 2.012 Note (mg) Methyltestosterone.

CSB 2.012 Note (mr) Methyltrienolone.

CSB 2.012 Note (n) Mibolerone.

CSB 2.012 Note (ng) 17alpha-methyl-delta1-dihydrotestosterone, which is also called 17-alpha-methyl-1-testosterone.

CSB 2.012 Note (nr) Nandrolone.

CSB 2.012 Note (o) 19-nor-4-androstenediol (3beta, 17beta-dihydroxyestr-4-ene; 3alpha, 17beta-dihydroxyestr-4-ene).

CSB 2.012 Note (og) 19-nor-5-androstenediol (3beta, 17beta-dihydroxyestr-5-ene; 3alpha, 17beta-dihydroxyestr-5-ene).

CSB 2.012 Note (or) 19-nor-4,9(10)-androstadienedione.

CSB 2.012 Note (p) 19-nor-4-androstenedione (estr-4-en-3,17-dione).

CSB 2.012 Note (pg) 19-nor-5-androstenedione (estr-5-en-3,17-dione).

CSB 2.012 Note (pr) Norbolethone.

CSB 2.012 Note (q) Norclostebol.

CSB 2.012 Note (qg) Norethandrolone.

CSB 2.012 Note (qr) Normethandrolone.

CSB 2.012 Note (r) Oxandrolone.

CSB 2.012 Note (rg) Oxymesterone.

CSB 2.012 Note (rr) Oxymetholone.

CSB 2.012 Note (s) Prostanozol.

CSB 2.012 Note (sg) Stanozolol.

CSB 2.012 Note (sr) Stenbolone.

CSB 2.012 Note (t) Testolactone.

CSB 2.012 Note (tg) Testosterone.

CSB 2.012 Note (tr) Tetrahydrogestrinone.

CSB 2.012 Note (u) Trenbolone.

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; correction made under s. 35.17, Stats., Register August 2022 No. 800; CR 23-018: cr. Register April 2024 No. 820, eff. 5-1-24.

CSB 2.012 Note CSB 2.93 Addition of Daridorexant to schedule IV. Section 961.20 (2) (cpm), Stats., is created to read:

CSB 2.012 Note 961.20 (2) (cpm) Daridorexant;

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; correction made under s. 35.17, Stats., Register August 2022 No. 800; CR 23-019: cr. Register April 2024 No. 820, eff. 5-1-24; correction made under s. 35.17, Stats., Register April 2024 No. 820.

CSB 2.012 Note CSB 2.94 Addition of seven (7) synthetic benzimidazole-opioid substances to schedule I. (1) Section 961.14 (2) (mm) and (pe), Stats., are renumbered to 961.14 (2) (xm) 3. and 5. and amended to read:

CSB 2.012 Note 961.14 (2) (xm) 3. Etonitazene (2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).

CSB 2.012 Note 961.14 (2) (xm) 5. Isotonitazene (N,N -diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benizimidazol-1-yl)ethan-1-amine).

CSB 2.012 Note (2) Section 961.14 (2) (xm) (intro.) 1., 2., 4., and 6. to 9., Stats., are created to read:

CSB 2.012 Note .14 (2) (xm) Synthetic Benzimidazole-opioid Substances, specifically including all of the following:

CSB 2.012 Note 1. Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).

CSB 2.012 Note 2. Etodesnitazene also known as Etazene (2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).

CSB 2.012 Note 4. Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5- nitro-1H-benzimidazol-1-yl)ethan-1- amine).

CSB 2.012 Note 6. Metodesnitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine).

CSB 2.012 Note 7. Metonitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine).

CSB 2.012 Note 8. N-pyrrolidino etonitazene also known as etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2- (pyrrolidin-1-yl)ethyl)-1H-benzimidazole).

CSB 2.012 Note 9. Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- propoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine).

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; correction in numbering of (1), (2) made under s. 13.92 (4) (b) 1., Stats., and correction in (1) made under s. 35.17, Stats., Register August 2022 No. 800; CR 23-020: cr. Register April 2024 No. 820, eff. 5-1-24; correction made under s. 35.17, Stats., Register April 2024 No. 820.

CSB 2.012 Note CSB 2.95 Addition of Ganaxolone to schedule V. Section 961.22 (11), Stats., is created to read:

CSB 2.012 Note 961.22 (11) Ganaxolone. Ganaxolone.

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; (title) created under s. 13.92 (4) (b) 2., Stats, Register August 2022 No. 800; CR 23-021: cr. Register April 2024 No. 820, eff. 5-1-24; (title) created under s. 13.92 (4) (b) 2. Register April 2024 No. 820.

CSB 2.012 Note CSB 2.96 Addition of Amineptine to schedule I. Section 961.14 (7) (r), Stats., is created to read:

CSB 2.012 Note 961.14 (7) (r) 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid, commonly known as Amineptine.

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March 2023 No. 807, eff. 3-6-23; correction made under s. 35.17, Stats., Register March 2023 No. 807; CR 23-068: cr. Register August 2024 No. 824, eff. 9-1-24.

CSB 2.012 Note CSB 2.97 Addition of Zipeprol to schedule I. Section 961.14 (2) (zm), Stats., is created to read:

CSB 2.012 Note 961.14 (2) (zm) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol).

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March 2023 No. 807, eff. 3-6-23: CR 23-069: cr. Register August 2024 No. 824, eff. 9-1-24.

CSB 2.012 Note CSB 2.98 Excluding [18F]FP-CIT from schedule II. Section 961.16 (2) (b), Stats., is amended to read:

CSB 2.012 Note 961.16 (2) (b) Coca leaves and any salt, compound, derivative, or preparation of coca leaves. Decocainized coca leaves or extractions which do not contain cocaine or ecgonine are excluded from this paragraph. [123I]Ioflupane is and [18 F]FP-CIT are excluded from this paragraph. The following substances and any of their salts, esters, isomers, and salts of esters and isomers that are theoretically possible within the specific chemical designation, are included in this paragraph:

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March 2023 No. 807, eff. 3-6-23.

CSB 2.012 Note CSB 2.99 Addition of Mesocarb to schedule I. Section 961.14 (7) (s), Stats., is created to read:

CSB 2.012 Note 961.14 (7) (s) N-phenyl-N’-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate, commonly known as Mesocarb.

CSB 2.012 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March 2023 No. 807, eff. 3-6-23.